What did Alcon pay for LENSAR, Inc.?

Alcon acquired LENSAR, Inc. for $356.0M in 2025, equivalent to 6.70x revenue. Target revenue was approximately $53.5M.

What does LENSAR, Inc. do?

LENSAR, Inc. is a medical devices business.

What multiple did Alcon pay for LENSAR, Inc.?

6.70x revenue, based on disclosed deal value of $356.0M and disclosed financials.

M&A TRANSACTION · 2025

LENSAR, Inc. acquired by Alcon

$356.0M· 6.70x revenue

Target

LENSAR, Inc.

Acquirer

Alcon

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$53.5M

EBITDA

—

Deal Value

$356.0M

EV/EBITDA

—

Context

This $356.0M acquisition of LENSAR, Inc. by Alcon sits in the medical devices sub-vertical. Alcon is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the LENSAR, Inc. acquisition.

Citation: ExitValue.ai. (2025). LENSAR, Inc. acquired by Alcon. https://exitvalue.ai/deals/lensar-inc-acquired-by-alcon-fairness-opi